2 Reviews
Initial comp can be decent. Churn means there's frequently open positions, and they're willing to help with immigration.
Outright openly toxic managers. Reputation means they can't source experienced talent and people leave as soon as they're qualified for better jobs. Visas are used to keep people at the company. Benefits are meh and promotion/raises are a joke.
The Global Biologics Contract Development & Manufacturing Organization Market size was estimated at USD 6,291. 23 million in 2021 and expected to reach USD 7,044. 93 million in 2022, and is projected to grow at a CAGR 12.New York, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the rele…
Pune, Maharashtra, India, October 11 2022 (Wiredrelease) MRfactors –:Global Biopharmaceutical Contract Manufacturing Market Revenue Analysis 2022 by Industry Size, Share, Growth, CAGR, and Revenue Overview Forecast to 2029The Biopharmaceutical Contract Manufacturing Market report includes an over...